4//SEC Filing
Adams Kendra 4
Accession 0001662579-24-000103
CIK 0001662579other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:17 PM ET
Size
8.6 KB
Accession
0001662579-24-000103
Insider Transaction Report
Form 4
Adams Kendra
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-11-07$6.04/sh−1,102$6,656→ 84,439 total - Exercise/Conversion
Common Stock
2024-11-07+3,750→ 85,541 total - Exercise/Conversion
Performance Restricted Stock Units
2024-11-07−3,750→ 10,500 totalExp: 2025-02-28→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001991929
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:17 PM ET
- Size
- 8.6 KB